| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.06 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.096 | 0.07 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |